Sandeep Rana, Ph.D.
Affiliations: | 2009 | Department of Chemistry | Kansas State University, Manhattan, KS, United States |
Area:
Organic Chemistry, Biochemistry, Pharmaceutical ChemistryGoogle:
"Sandeep Rana"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Duy Hua | grad student | 2009 | Kansas State University | |
| (Synthesis, biophysical analysis and biological evaluation of tricyclic pyrones and pyridinones as anti-Alzheimer agents.) | ||||
Collaborators
Sign in to add collaborator| Amarnath (Amar) Natarajan | collaborator | 2012-2019 | University of Nebraska Medical Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rana S, Dranchak P, Dahlin JL, et al. (2023) Methotrexate-based PROTACs as DHFR-specific chemical probes. Cell Chemical Biology |
| Rana S, Kour S, Kizhake S, et al. (2022) Dimers of isatin derived α-methylene-γ-butyrolactone as potent anti-cancer agents. Bioorganic & Medicinal Chemistry Letters. 65: 128713 |
| Rana S, Mallareddy JR, Singh S, et al. (2021) Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase. Cancers. 13 |
| Sagar S, Singh S, Mallareddy JR, et al. (2021) Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy. European Journal of Medicinal Chemistry. 222: 113579 |
| King HM, Rana S, Kubica SP, et al. (2021) Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax. Bioorganic & Medicinal Chemistry Letters. 128061 |
| Al-Mugotir M, Lovelace JJ, George J, et al. (2021) Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction. Plos One. 16: e0248941 |
| Robb CM, Kour S, Contreras JI, et al. (2020) Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 11: 2462-2463 |
| Rana S, Kour S, Sonawane YA, et al. (2020) Symbiotic Prodrugs (SymProDs) Dual Targeting of NFkappaB and CDK. Chemical Biology & Drug Design |
| Shamsi F, Hasan P, Queen A, et al. (2020) Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy. Bioorganic Chemistry. 98: 103754 |
| Tom EC, Mushtaq I, Mohapatra BC, et al. (2020) EHD1 and RUSC2 control basal EGFR cell surface expression and recycling. Molecular and Cellular Biology |